Singapore vs South-East Asia (WHO region): Hypertension effective treatment coverage (controlled hypertension)
Singapore
37.6%
in 2019
South-East Asia (WHO region)
13.6%
in 2019
Singapore rank
11th
South-East Asia (WHO region) rank
9th
Hypertension effective treatment coverage (controlled hypertension) over time
- Singapore
- South-East Asia (WHO region)
How they compare
Singapore currently reports 37.6% against 13.6% in South-East Asia (WHO region), a difference of 24.0%.
That makes Singapore's figure about 2.8 times South-East Asia (WHO region)'s.
Across all 30 years both countries report, Singapore has been ahead every year.
Singapore ranks 11th and South-East Asia (WHO region) ranks 9th of 193 countries.
Singapore has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Singapore | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.6% | 2.5% | 4.1% | Singapore |
| 2000s | 16.4% | 5.8% | 10.6% | Singapore |
| 2010s | 31.5% | 10.9% | 20.6% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Singapore or South-East Asia (WHO region)?
- Singapore, at 37.6% against 13.6% in South-East Asia (WHO region) as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Singapore and South-East Asia (WHO region)?
- 24.0%, with Singapore ahead.
- How many years of comparable data are there for Singapore and South-East Asia (WHO region)?
- 30 years are reported by both, from 1990 to 2019.
- How do Singapore and South-East Asia (WHO region) rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Singapore ranks 11th and South-East Asia (WHO region) ranks 9th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.